Make sure you know where the boundaries lie.
The lines between industry and practice blur as retina evolves. Sure, the demarcations between the two are obvious in some scenarios (physicians cannot take kickbacks for using certain products, for example), but as industry grows to rely on physicians (and vice versa), doctors who work with industry enter brackish water.
Best be prepared. For young retina doctors, planning your future can prevent trouble with such line blurring. Knowing, for example, how and why collaboration with industry fits your future will help you map your career path. Emmett T. Cunningham Jr, MD, PhD, MPH, sits down for an interview with NRMD to review the pros and cons of industry collaboration. His message: It’s not right for everyone, but it could be right of you.
Some retina doctors, after 4 years of medical school, 2 years of residency, and 2 years of fellowship (to say nothing of other years dedicated to education), choose to go to school yet again to earn a masters of business administration degree. But is it even worth it? Probably, writes Peter Karth, MD, MBA. The adjustment period may not be pretty, but then again, comfort never generates innovation or deeper understanding of a complex system.
Readers will find value in our other cover stories, too. Inventors who wish to know how to protect their ideas can read yet another article in our cover focus, where industry executive Timothy Buckley, MBA, BSME, reviews the first steps of bringing an invention to market. Readers who will soon depart fellowship and want to pursue a career in academic retina should check out a different cover focus article, where the triumvirate of Daniel Chao, MD, PhD; Jayanth Sridhar, MD; and Eric Nudleman, MD, PhD, offer advice on landing a job in academia. Retina specialists considering a switch from academic medicine to private practice may find useful the story of one doctor’s career change: Also in our cover focus, Paul Hahn, MD, PhD, discusses the factors that influenced his move from a world-class academic institution to private practice in New Jersey.
We hope you didn’t throw out your shoulder handling this issue of NRMD; as a savvy reader, you likely noticed that this issue is the largest (and heaviest) in our publication history. This is because a number of talented writers have created new columns within the publication and have expanded the normal borders of columns established long ago. Eyetube’s Retina Chief Michael A. Klufas, MD, checks in twice during this issue: to review trocar/cannula systems available in the United States for Break It Down; and to introduce the new column Meanwhile, on Eyetube. Benjamin J. Thomas, MD, introduces the column Global Retina, the brainchild of co-Chief Medical Editor Jonathan Prenner, MD, and Dr. Thomas at the 2016 Retina Fellows’ Forum in Chicago.
Even with all the young blood, plenty of mentoring faces make their way in this issue. Allen Chiang, MD, asks four retina mentors (Sunir Garg, MD; Allen Ho, MD; co-Chief Medical Editor Richard Kaiser, MD; and Rishi Singh, MD) to profile a plethora of retina meetings. Readers who want to know quirky personal details about retina mentors, such as what television shows they are embarrassed to admit they watch, should check out the column 3 For 3, where Audina Berrocal, MD: Brandon Busbee, MD; and Elias Reichel, MD, share a few interesting tidbits.
As we warned, this issue is heavy. Perhaps some calisthenics are in order before you read further.
Co-Chief Medical Editor Richard Kaiser, MD
• professor of ophthalmology, Jefferson Medical College; co-director, retina fellowship, Wills Eye Hospital; both in Philadelphia
• @Retinadoc44; email@example.com
Co-Chief Medical Editor Jonathan Prenner, MD
• associate clinical professor, department of ophthalmology, Rutgers Robert Wood Johnson Medical School, New Brunswick, N.J.
• @jlprenner; firstname.lastname@example.org